Printer-friendly versionPrinter-friendly version Share this

Photo: An employee at the County Psychiatric Hospital gets her first dose of COVID-19 vaccine in December

By Katie Cadiao, County of San Diego Communications Office

April 28, 2021 (San Diego) -- The County is resuming vaccinations with the Johnson & Johnson vaccine after the California Department of Public Health gave the green light to do so over the weekend.

Vaccinations with Johnson & Johnson were temporarily paused earlier this month while the U.S. Food and Drug Administration studied adverse reactions in a small number of recipients. The FDA concluded April 23 that the benefits of the vaccine outweigh its risks and approved it for emergency use. Following the subsequent findings of the Western States Scientific Safety Review Workgroup, CDPH approved the vaccine’s usage.

Women under the age of 50 should be aware of the rare but increased risk of blood clots after vaccination with the Johnson & Johnson vaccine and talk to their medical providers about other options if they have concerns about the Johnson & Johnson vaccine.

The County of San Diego currently has about 12,000 doses of the Johnson & Johnson vaccine available and will offer them at mobile vaccination sites and walk-up vaccine pods. The single-dose Johnson & Johnson vaccine will also be used to vaccinate homebound individuals and agricultural workers who are often more difficult to reach for a second dose.

Available Vaccine Appointments

Thanks to Johnson & Johnson vaccinations resuming and a steady supply of incoming vaccine shipments, vaccination sites across the County currently have appointments available for the coming days. A new vaccination location, the Linda Vista Vaccine Site at the University of San Diego, opened yesterday. The site will be open from 9 a.m. to 3:30 p.m.

You can research appointment times and locations at

Vaccine recipients will be informed during sign-up which vaccine they will receive, which is standard practice. Those signing up for appointments on MyTurn can see which of the three available vaccines, Johnson & Johnson, Moderna or Pfizer, will be offered to them.

Vaccination Progress:

  • Over 2.72 million COVID-19 vaccine doses have been delivered to the region, and more than 2.53 million have been logged as administered. This number includes both County residents and those who work in San Diego County.
  • Overall, close to 1.39 million County residents have received at least one shot of the two-dose vaccine. That’s 51.7% of those eligible.
  • Of those vaccinated to date, over 935,000 County residents, or 34.8% of San Diegans 16 and older, are fully immunized.
  • The goal is to fully vaccinate 75% of San Diego County residents 16 and older or 2,017,011 people. To date, 68.9% of the goal population has received at least one vaccine and 46.4% are fully vaccinated.
  • Those who received the one-dose Johnson & Johnson vaccine, which was approved for emergency use by the FDA on Friday, April 23, 2021 following a pause for a study of adverse reactions in a small number of recipients, are being added to the total of fully vaccinated San Diegans.
  • The difference between doses shipped and the number of vaccinations administered represents approximately what is expected to be used in the next seven days and doses still to be entered in the record system.
  • More information about vaccine distribution can be found on the County’s vaccination dashboard. For vaccination opportunities, visit

State Metrics:

  • San Diego County’s state-calculated, adjusted case rate is currently 6.1 cases per 100,000 residents (as of April 20).
  • The County remains in the Orange Tier or Tier 3 under the state’s new guidance. The California Department of Public Health indicates that unless there are extenuating circumstances, such as low rate of vaccine uptake, a county will only move to a more restrictive tier if hospitalizations are increasing significantly among vulnerable individuals, especially among vaccinated individuals, and both testing positivity and adjusted case rates show a concerning increase in transmission. This is currently not the case in the region.
  • Currently, the testing positivity percentage is 2.4%, placing the County in Tier 3 or the Orange Tier.
  • The County’s health equity metric, which looks at the testing positivity for areas with the lowest healthy conditions, is 3.0% and is also in the Orange Tier or Tier 3.
  • CDPH assesses counties on a weekly basis. The next report is scheduled for Tuesday, April 27.

Community Setting Outbreaks:

  • No new community outbreaks were confirmed April 25.
  • Seven new community outbreaks were confirmed April 24, three in business settings, two in restaurant/bar settings, one in a grocery setting and one in a retail setting.
  • Three new community outbreaks were confirmed April 23, one in a business setting, one in a TK-12 school setting, and one in a retail setting.
  • In the past seven days (April 19 through April 25), 25 community outbreaks were confirmed.
  • The number of community outbreaks remains above the trigger of seven or more in seven days.
  • A community setting outbreak is defined as three or more COVID-19 cases in a setting and in people of different households over the past 14 days.


  • 7,737 tests were reported to the County on April 25, and the percentage of new positive cases was 2%.
  • The 14-day rolling average percentage of positive cases is 1.8%. Target is less than 8.0%.
  • The 7-day, daily average of tests is 12,959.

Cases, Hospitalizations and ICU Admissions:

  • 129 COVID-19 cases were reported to the County on April 25. The region’s total is now 275,540.
  • 15,164 or 5.5% of all cases have required hospitalization.
  • 1,673 or 0.6% of all cases and 11% of hospitalized cases had to be admitted to an intensive care unit.


  • No new COVID-19 deaths were reported April 25. The region’s total is 3,692.
  • Four additional COVID-19 deaths were reported on April 24.
  • All of these deaths occurred in December and were just added to the list after a rigorous review of death certificates that were incorrect or incomplete and required the analysis of the patients’ medical records to determine if they were COVID-19 deaths.
  • One woman and three men died between Dec. 4 and Dec. 11.
  • Of the people whose deaths were reported on Sunday, two were 80 years of age or older, one was in their 70s and one was in their 60s.
  • Three had underlying medical conditions and one has medical history pending.
  • Four additional deaths were reported on April 23.
  • Two women and two men died between April 12 and April 22.
  • Of the people whose deaths were reported on Saturday, one was 80 years of age or older, two were in their 70s and one was in their 50s.
  • All had underlying medical conditions.

Error message

Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at to help us keep people safe and informed across our region.


My opinion on the J&J vaccine


The blood clots were one in a million. The reason, the J&J vaccine was "paused," from what I have read that made the most sense to me and "sounded right," (immediately after they were paused- sorry I don't have the source), was that the J&J vaccine was paused was because the TYPICAL TREATMENT for this rare type of blood clot was DANGEROUS for the ones linked to the vaccine. Doctors needed to be educated on the correct treatment for this rare clot, when it occurs within a couple weeks of receiving the J&J vaccine. Now that word is out, if you get one of these rare blood clots, your doctor won't accidently hurt you with the wrong treatment.

All that said: in my opinion premenopausal women should refuse the J&J vaccine. (the educated hypothesis based on who had these horrible rare blood clots is that the clots may have something to do with women's hormones)

SPECULATION: the Pfizer and Moderna vaccines use very new ("novel,: they call it, same as the "novel coronavirus"), vaccine technology. We only know their effects for one year after use. For vaccine skeptics, J&J uses more traditional methods, so J&J might (oddly enough) actually be the best option for cynics (don't read too much into that LOL).

more speculation: Some people who get COVID have dangerouos blood clots. So something that MIMICS COVID, could it stand to reason that, in some cases, it could have a similar effect as COVID itself? Yes, J&J is much better than nothing, but it's nice to know that even a one in a million chance of something life threatening from these vaccines could cause them to be paused and investigated further. The vaccines are safe. Gov. Newsom even took the J&J vaccine, just because all the other public officials took Pfizer or Moderna, so he made a judgement call to take the J&J vaccine, to set an example and put his money where his mouth is. What a nice civic-minded fellow. It's awfully nice to have a good governor during a pandemic.

God bless you and stay safe.